CV (until May 2008)

CV: Davood Beiki
syndrome X", BMC Nucl Med 2006; 6: 1 DOI: 10.1186/1471-2385-6-
1. [English]
37. Gholamrezanezhad A., Moinian D., Eftekhari M., Beiki D. "The prevalence
and significance of increased gastric wall radiotracer uptake in sestamibi
myocardial perfusion SPECT", Int J Cardiovas Imag 2006; 6: 1 DOI
10.1007/s10554-005-9055-6. [English]
38. Saghari M, Gholamrezanezhad A, Mirpour S, Eftekhari M, Takavar A, Fard-
Esfahani A, Fallahi B, Beiki D. "Efficacy of radioiodine therapy in the
treatment of elevated serum thyroglobulin in patients with differentiated
thyroid carcinoma and negative whole-body iodine scan", Nucl Med
Commun 2006 Jul; 27(7):567-72. [English]
39. Fallahi B., Beiki D., Assadi M., Fard-Esfahani A, "Thallium-201 single
photon emission tomography after injecting an antimuscarinic agent
compared with computed tomography for the diagnosis of recurrent
colorectal cancer: Report of three cases", Hellenic Journal of Nuclear
Medicine, 2006; 9(2): 106-108. [English]
40. Eftekhari M., Gholamrezanezhad A., Izadyar S., Esmaili J., Mirpour S.,
Saghari M., Fard-Esfahani A., Fallahi Sichani B., Beiki D., “Catheter related
artifacts on bone scanes: report of two cases”, Iranian Journal of
Nuclear Medicine, 2006; 14(25): 21-25. [English]
41. Eftekhari M., Assadi M., Kazemi M., Saghari M., Mojtahedi A., Fard-Esfahani A.,
Sichani BF., Beiki D., “Brain perfusion single photon emission computed
tomography findings in patients with posttraumatic anosmia and
comparison with radiological imaging”, American Journal of Rhinology,
2006; 20(6): 577-81. [English]
42. Fard-Esfahani A., Fallahi B., Khatami K., Eftekhari M., Saghari M., Beiki D.,
Ansari-Gilani K., Takavar A., “Agreement of two methods of planar and
SPECT scintigraphy with 99mTc-RBC in detection of liver hemangioma”,
Iranian Journal of Nuclear Medicine, 2006; 14(26): 8-12. [Persian]
43. Gholamrezanezhad A., Mirpour S., Esfahani AF., Saghari M., Mirpour K.,
Beiki D., Soheilifar M., “A correlative study comparing current different
methods of calculating left ventricular ejection fraction”, Nucl Med
Commun 2007; 28(1):41-48. [English]
44. Gholamrezanezhad A., Saghari M., Mirpour S., Beiki D., Javan S.,
Abdollahzadeh J., “On-levothyroxine measurement of thyroglobulin is not a
reliable test for the follow-up of patients at high risk for remnant/recurrent
differentiated thyroid carcinoma”, Pol J Endocrinol 2007; 58(2): 100-
104. [English]
45. Beiki D., Gholamrezanezhad A., Mirpour S., Fallahi B., Saghari M.,
Eftekhari M., Fard-Esfahani A., Hajimahmoudi H., “The relationship
between dyspepsia and increased radiotracer uptake in the gastric wall
during 99mTc-MIBI myocardial perfusion imaging”, J Mazandaran Univ
Med Sci 2007; 16(56): 1-8 [Persian]
46. Fard-Esfahani A., Fallahi B., Saghari M., Eftekhari M., Beiki D., “Myocardial
Perfusion Scan Accuracy in Detection of Coronary Artery Disease -
Comparison with Exercise Stress Test”, Iranian Journal of Nuclear
Medicine, 2007; 15(27): 16-23. [Persian]
47. Fard-Esfahani A., Mirshekarpour H., Fallahi B., Eftekhari M., Saghari M.,
Beiki D., Ansari-Gilani K., Takavar A., “The effect of high-dose radioiodine
treatment on lacrimal gland function in patients with differentiated thyroid
carcinoma”, Clin Nucl Med. 2007; 32(9): 696-9. [English]
48. Gholamrezanezhad A, Fard-Esfahani A, Sadeghi-Tari A, Mirpour S, Saghari
M, Eftekhari M, Fallahi B, Beiki D, Poormoslemi A, Tarbiat A., "Quantitative
assessment of dacryoscintigraphic images in the evaluation of epiphora",
Orbit. 2007 Dec;26(4):229-35. [English]
49. Gholamrezanezhad A, Bagheri M, Mohammadnezhad M, Mirpour S, Majd
Ardekani J, Alimoghadam K, Bashtar M, Beiki D, Ansari Gilani K, Saghari
M, Ghavamzadeh A, Malekzadeh R., " The First Experience of Stem Cell
Labeling in Iran Using 111In- Oxine", Iran J Nucl Med 2007; 15(2):25-
27. [Persian]
mhtml:file://C:\Documents and Settings\Dr\Desktop\CV Davood Beiki.mht
Page 5 of 18
2008/05/30